These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31689477)

  • 21. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Zee B; Warr D; Latreille J; Kaizer L; Pater J
    Support Care Cancer; 1997 Jul; 5(4):307-13. PubMed ID: 9257427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy.
    Shih J; Leutwyler H; Ritchie C; Paul SM; Levine JD; Cooper B; Wright F; Conley YP; Miaskowski C
    Support Care Cancer; 2017 Mar; 25(3):783-793. PubMed ID: 27766422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.
    Tejada M; Viele C; Kober KM; Cooper BA; Paul SM; Dunn LB; Hammer MJ; Wright F; Conley YP; Levine JD; Miaskowski C
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31361899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK
    Bošnjak SM; Gralla RJ; Schwartzberg L
    Support Care Cancer; 2017 May; 25(5):1661-1671. PubMed ID: 28108820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Options in the treatment of chemotherapy-induced emesis.
    Pendergrass KB
    Cancer Pract; 1998; 6(5):276-81. PubMed ID: 9767346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy.
    Wright F; Hammer M; Paul SM; Aouizerat BE; Kober KM; Conley YP; Cooper BA; Dunn LB; Levine JD; DEramo Melkus G; Miaskowski C
    Cytokine; 2017 Mar; 91():187-210. PubMed ID: 28110208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea.
    Peoples AR; Culakova E; Heckler CE; Shayne M; O'Connor TL; Kirshner JJ; Bushunow PW; Morrow GR; Roscoe JA
    Support Care Cancer; 2019 Dec; 27(12):4597-4605. PubMed ID: 30929028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of chemotherapy-induced nausea to the frequency of pericardium 6 digital acupressure.
    Lee J; Dibble S; Dodd M; Abrams D; Burns B
    Oncol Nurs Forum; 2010 Nov; 37(6):E419-25. PubMed ID: 21059575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.
    Patel P; Lavoratore SR; Flank J; Kemp M; Vennettilli A; Vol H; Taylor T; Zelunka E; Maloney AM; Nathan PC; Dupuis LL
    Support Care Cancer; 2020 Feb; 28(2):933-938. PubMed ID: 31177392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control.
    Schnell FM
    Oncologist; 2003; 8(2):187-98. PubMed ID: 12697943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
    Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy.
    Suskin JA; Paul S; Stuckey AR; Conley YP; Miaskowski C; Dunn LB
    Support Care Cancer; 2022 Dec; 31(1):32. PubMed ID: 36517706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.
    Bischel LE; Ritchie C; Kober KM; Paul SM; Cooper BA; Chen LM; Levine JD; Hammer M; Wright F; Miaskowski C
    Eur J Oncol Nurs; 2016 Aug; 23():115-23. PubMed ID: 27456383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics Associated With Physical Function Trajectories in Older Adults With Cancer During Chemotherapy.
    Wong ML; Paul SM; Mastick J; Ritchie C; Steinman MA; Walter LC; Miaskowski C
    J Pain Symptom Manage; 2018 Nov; 56(5):678-688.e1. PubMed ID: 30144536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.